APO Research
Talk to an analyst

APO RESEARCH · REPORT

Herpes Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Herpes Treatment Market Analysis and Forecast 2026-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchHerpes Treatment Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Herpes Treatment Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Herpes Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Herpes Treatment Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Herpes Treatment Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Herpes Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Herpes Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Herpes Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Herpes Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Herpes Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Herpes Treatment include Abbott, Teva Pharmaceutical Industries, Novartis, Merck, Mylan, GlaxoSmithKline, Vical and Gilead, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Herpes Treatment, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Herpes Treatment, also provides the sales of main regions and countries. Of the upcoming market potential for Herpes Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Herpes Treatment sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Herpes Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Herpes Treatment sales, projected growth trends, production technology, application and end-user industry.

Herpes Treatment Segment by Company

Abbott

Teva Pharmaceutical Industries

Novartis

Merck

Mylan

GlaxoSmithKline

Vical

Gilead

Herpes Treatment Segment by Type

Famciclovir

Valacyclovir

Acyclovir

Herpes Treatment Segment by Application

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Drug Stores

Herpes Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Herpes Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Herpes Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Herpes Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Herpes Treatment in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Herpes Treatment manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Herpes Treatment sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Herpes Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Famciclovir Major Manufacturers Table 3. Valacyclovir Major Manufacturers Table 4. Acyclovir Major Manufacturers Table 5. Global Herpes Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Retail Pharmacies Major Manufacturers Table 7. Hospital Pharmacies Major Manufacturers Table 8. Online Pharmacies Major Manufacturers Table 9. Drug Stores Major Manufacturers Table 10. Herpes Treatment Industry Trends Table 11. Herpes Treatment Industry Drivers Table 12. Herpes Treatment Industry Opportunities and Challenges Table 13. Herpes Treatment Industry Restraints Table 14. Global Herpes Treatment Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Herpes Treatment Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Herpes Treatment Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Herpes Treatment Revenue Market Share by Region (2021-2026) Table 18. Global Herpes Treatment Revenue Market Share by Region (2027-2032) Table 19. Global Herpes Treatment Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global Herpes Treatment Sales by Region (2021-2026) & (k units) Table 21. Global Herpes Treatment Sales by Region (2027-2032) & (k units) Table 22. Global Herpes Treatment Sales Market Share by Region (2021-2026) Table 23. Global Herpes Treatment Sales Market Share by Region (2027-2032) Table 24. Global Herpes Treatment Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Herpes Treatment Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Herpes Treatment Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Herpes Treatment Sales Market Share by Manufacturers (2021-2026) Table 28. Global Herpes Treatment Sales Price (US$/unit) of Manufacturers (2021-2026) Table 29. Global Herpes Treatment Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Herpes Treatment Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Herpes Treatment Manufacturers, Product Type & Application Table 32. Global Herpes Treatment Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Herpes Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Herpes Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Herpes Treatment Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Herpes Treatment Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Herpes Treatment Revenue Market Share by Type (2021-2026) Table 39. Global Herpes Treatment Revenue Market Share by Type (2027-2032) Table 40. Global Herpes Treatment Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global Herpes Treatment Sales by Type (2021-2026) & (k units) Table 42. Global Herpes Treatment Sales by Type (2027-2032) & (k units) Table 43. Global Herpes Treatment Sales Market Share by Type (2021-2026) Table 44. Global Herpes Treatment Sales Market Share by Type (2027-2032) Table 45. Global Herpes Treatment Price by Type (2021-2026) & (US$/unit) Table 46. Global Herpes Treatment Price by Type (2027-2032) & (US$/unit) Table 47. Global Herpes Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Herpes Treatment Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Herpes Treatment Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Herpes Treatment Revenue Market Share by Application (2021-2026) Table 51. Global Herpes Treatment Revenue Market Share by Application (2027-2032) Table 52. Global Herpes Treatment Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global Herpes Treatment Sales by Application (2021-2026) & (k units) Table 54. Global Herpes Treatment Sales by Application (2027-2032) & (k units) Table 55. Global Herpes Treatment Sales Market Share by Application (2021-2026) Table 56. Global Herpes Treatment Sales Market Share by Application (2027-2032) Table 57. Global Herpes Treatment Price by Application (2021-2026) & (US$/unit) Table 58. Global Herpes Treatment Price by Application (2027-2032) & (US$/unit) Table 59. Abbott Company Information Table 60. Abbott Business Overview Table 61. Abbott Herpes Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 62. Abbott Herpes Treatment Product Portfolio Table 63. Abbott Recent Development Table 64. Teva Pharmaceutical Industries Company Information Table 65. Teva Pharmaceutical Industries Business Overview Table 66. Teva Pharmaceutical Industries Herpes Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Teva Pharmaceutical Industries Herpes Treatment Product Portfolio Table 68. Teva Pharmaceutical Industries Recent Development Table 69. Novartis Company Information Table 70. Novartis Business Overview Table 71. Novartis Herpes Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Novartis Herpes Treatment Product Portfolio Table 73. Novartis Recent Development Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck Herpes Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Merck Herpes Treatment Product Portfolio Table 78. Merck Recent Development Table 79. Mylan Company Information Table 80. Mylan Business Overview Table 81. Mylan Herpes Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Mylan Herpes Treatment Product Portfolio Table 83. Mylan Recent Development Table 84. GlaxoSmithKline Company Information Table 85. GlaxoSmithKline Business Overview Table 86. GlaxoSmithKline Herpes Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. GlaxoSmithKline Herpes Treatment Product Portfolio Table 88. GlaxoSmithKline Recent Development Table 89. Vical Company Information Table 90. Vical Business Overview Table 91. Vical Herpes Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Vical Herpes Treatment Product Portfolio Table 93. Vical Recent Development Table 94. Gilead Company Information Table 95. Gilead Business Overview Table 96. Gilead Herpes Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Gilead Herpes Treatment Product Portfolio Table 98. Gilead Recent Development Table 99. North America Herpes Treatment Revenue by Type (2021-2026) & (US$ Million) Table 100. North America Herpes Treatment Revenue by Type (2027-2032) & (US$ Million) Table 101. North America Herpes Treatment Sales by Type (2021-2026) & (k units) Table 102. North America Herpes Treatment Sales by Type (2027-2032) & (k units) Table 103. North America Herpes Treatment Sales Price by Type (2021-2026) & (US$/unit) Table 104. North America Herpes Treatment Sales Price by Type (2027-2032) & (US$/unit) Table 105. North America Herpes Treatment Revenue by Application (2021-2026) & (US$ Million) Table 106. North America Herpes Treatment Revenue by Application (2027-2032) & (US$ Million) Table 107. North America Herpes Treatment Sales by Application (2021-2026) & (k units) Table 108. North America Herpes Treatment Sales by Application (2027-2032) & (k units) Table 109. North America Herpes Treatment Sales Price by Application (2021-2026) & (US$/unit) Table 110. North America Herpes Treatment Sales Price by Application (2027-2032) & (US$/unit) Table 111. North America Herpes Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Herpes Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 113. North America Herpes Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 114. North America Herpes Treatment Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 115. North America Herpes Treatment Sales by Country (2021-2026) & (k units) Table 116. North America Herpes Treatment Sales by Country (2027-2032) & (k units) Table 117. North America Herpes Treatment Sales Price by Country (2021-2026) & (US$/unit) Table 118. North America Herpes Treatment Sales Price by Country (2027-2032) & (US$/unit) Table 119. United States Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 120. Canada Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 121. Mexico Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 122. Europe Herpes Treatment Revenue by Type (2021-2026) & (US$ Million) Table 123. Europe Herpes Treatment Revenue by Type (2027-2032) & (US$ Million) Table 124. Europe Herpes Treatment Sales by Type (2021-2026) & (k units) Table 125. Europe Herpes Treatment Sales by Type (2027-2032) & (k units) Table 126. Europe Herpes Treatment Sales Price by Type (2021-2026) & (US$/unit) Table 127. Europe Herpes Treatment Sales Price by Type (2027-2032) & (US$/unit) Table 128. Europe Herpes Treatment Revenue by Application (2021-2026) & (US$ Million) Table 129. Europe Herpes Treatment Revenue by Application (2027-2032) & (US$ Million) Table 130. Europe Herpes Treatment Sales by Application (2021-2026) & (k units) Table 131. Europe Herpes Treatment Sales by Application (2027-2032) & (k units) Table 132. Europe Herpes Treatment Sales Price by Application (2021-2026) & (US$/unit) Table 133. Europe Herpes Treatment Sales Price by Application (2027-2032) & (US$/unit) Table 134. Europe Herpes Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Europe Herpes Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. Europe Herpes Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. Europe Herpes Treatment Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 138. Europe Herpes Treatment Sales by Country (2021-2026) & (k units) Table 139. Europe Herpes Treatment Sales by Country (2027-2032) & (k units) Table 140. Europe Herpes Treatment Sales Price by Country (2021-2026) & (US$/unit) Table 141. Europe Herpes Treatment Sales Price by Country (2027-2032) & (US$/unit) Table 142. Germany Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 143. France Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 144. U.K. Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 145. Italy Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 146. Russia Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 147. Spain Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 148. Netherlands Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 149. Switzerland Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 150. Sweden Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 151. Poland Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 152. China Herpes Treatment Revenue by Type (2021-2026) & (US$ Million) Table 153. China Herpes Treatment Revenue by Type (2027-2032) & (US$ Million) Table 154. China Herpes Treatment Sales by Type (2021-2026) & (k units) Table 155. China Herpes Treatment Sales by Type (2027-2032) & (k units) Table 156. China Herpes Treatment Sales Price by Type (2021-2026) & (US$/unit) Table 157. China Herpes Treatment Sales Price by Type (2027-2032) & (US$/unit) Table 158. China Herpes Treatment Revenue by Application (2021-2026) & (US$ Million) Table 159. China Herpes Treatment Revenue by Application (2027-2032) & (US$ Million) Table 160. China Herpes Treatment Sales by Application (2021-2026) & (k units) Table 161. China Herpes Treatment Sales by Application (2027-2032) & (k units) Table 162. China Herpes Treatment Sales Price by Application (2021-2026) & (US$/unit) Table 163. China Herpes Treatment Sales Price by Application (2027-2032) & (US$/unit) Table 164. Asia Herpes Treatment Revenue by Type (2021-2026) & (US$ Million) Table 165. Asia Herpes Treatment Revenue by Type (2027-2032) & (US$ Million) Table 166. Asia Herpes Treatment Sales by Type (2021-2026) & (k units) Table 167. Asia Herpes Treatment Sales by Type (2027-2032) & (k units) Table 168. Asia Herpes Treatment Sales Price by Type (2021-2026) & (US$/unit) Table 169. Asia Herpes Treatment Sales Price by Type (2027-2032) & (US$/unit) Table 170. Asia Herpes Treatment Revenue by Application (2021-2026) & (US$ Million) Table 171. Asia Herpes Treatment Revenue by Application (2027-2032) & (US$ Million) Table 172. Asia Herpes Treatment Sales by Application (2021-2026) & (k units) Table 173. Asia Herpes Treatment Sales by Application (2027-2032) & (k units) Table 174. Asia Herpes Treatment Sales Price by Application (2021-2026) & (US$/unit) Table 175. Asia Herpes Treatment Sales Price by Application (2027-2032) & (US$/unit) Table 176. Asia Herpes Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Asia Herpes Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. Asia Herpes Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. Asia Herpes Treatment Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 180. Asia Herpes Treatment Sales by Country (2021-2026) & (k units) Table 181. Asia Herpes Treatment Sales by Country (2027-2032) & (k units) Table 182. Asia Herpes Treatment Sales Price by Country (2021-2026) & (US$/unit) Table 183. Asia Herpes Treatment Sales Price by Country (2027-2032) & (US$/unit) Table 184. Japan Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 185. South Korea Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 186. India Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 187. Australia Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 188. Taiwan Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 189. Southeast Asia Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 190. SAMEA Herpes Treatment Revenue by Type (2021-2026) & (US$ Million) Table 191. SAMEA Herpes Treatment Revenue by Type (2027-2032) & (US$ Million) Table 192. SAMEA Herpes Treatment Sales by Type (2021-2026) & (k units) Table 193. SAMEA Herpes Treatment Sales by Type (2027-2032) & (k units) Table 194. SAMEA Herpes Treatment Sales Price by Type (2021-2026) & (US$/unit) Table 195. SAMEA Herpes Treatment Sales Price by Type (2027-2032) & (US$/unit) Table 196. SAMEA Herpes Treatment Revenue by Application (2021-2026) & (US$ Million) Table 197. SAMEA Herpes Treatment Revenue by Application (2027-2032) & (US$ Million) Table 198. SAMEA Herpes Treatment Sales by Application (2021-2026) & (k units) Table 199. SAMEA Herpes Treatment Sales by Application (2027-2032) & (k units) Table 200. SAMEA Herpes Treatment Sales Price by Application (2021-2026) & (US$/unit) Table 201. SAMEA Herpes Treatment Sales Price by Application (2027-2032) & (US$/unit) Table 202. SAMEA Herpes Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. SAMEA Herpes Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. SAMEA Herpes Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. SAMEA Herpes Treatment Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 206. SAMEA Herpes Treatment Sales by Country (2021-2026) & (k units) Table 207. SAMEA Herpes Treatment Sales by Country (2027-2032) & (k units) Table 208. SAMEA Herpes Treatment Sales Price by Country (2021-2026) & (US$/unit) Table 209. SAMEA Herpes Treatment Sales Price by Country (2027-2032) & (US$/unit) Table 210. Brazil Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 211. Argentina Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 212. Chile Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 213. Colombia Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 214. Peru Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 215. Saudi Arabia Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 216. Israel Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 217. UAE Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 218. Turkey Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 219. Iran Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 220. Egypt Herpes Treatment Revenue (2021-2032) & (US$ Million) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Herpes Treatment Distributors List Table 224. Herpes Treatment Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Herpes Treatment Image Figure 2. Global Herpes Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Herpes Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Famciclovir Image Figure 5. Valacyclovir Image Figure 6. Acyclovir Image Figure 7. Global Herpes Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Herpes Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 9. Retail Pharmacies Image Figure 10. Hospital Pharmacies Image Figure 11. Online Pharmacies Image Figure 12. Drug Stores Image Figure 13. Global Herpes Treatment Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Herpes Treatment Revenue (2021-2032) & (US$ Million) Figure 15. Global Herpes Treatment Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Herpes Treatment Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Herpes Treatment Revenue Market Share by Region (2021-2032) Figure 18. Global Herpes Treatment Sales (2021-2032) & (k units) Figure 19. Global Herpes Treatment Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Herpes Treatment Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Herpes Treatment Sales YoY (2021-2032) & (k units) Figure 22. Europe Herpes Treatment Sales YoY (2021-2032) & (k units) Figure 23. China Herpes Treatment Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) Herpes Treatment Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa Herpes Treatment Sales YoY (2021-2032) & (k units) Figure 26. Global Herpes Treatment Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Herpes Treatment Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Herpes Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Herpes Treatment Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Herpes Treatment Revenue Market Share by Type (2021-2032) Figure 32. Global Herpes Treatment Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global Herpes Treatment Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Herpes Treatment Sales Market Share by Type (2021-2032) Figure 35. Global Herpes Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Herpes Treatment Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Herpes Treatment Revenue Market Share by Application (2021-2032) Figure 38. Global Herpes Treatment Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Herpes Treatment Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Herpes Treatment Sales Market Share by Application (2021-2032) Figure 41. North America Herpes Treatment Revenue Share by Type (2021-2032) Figure 42. North America Herpes Treatment Sales Share by Type (2021-2032) Figure 43. North America Herpes Treatment Revenue Share by Application (2021-2032) Figure 44. North America Herpes Treatment Sales Share by Application (2021-2032) Figure 45. North America Herpes Treatment Revenue Share by Country (2021-2032) Figure 46. North America Herpes Treatment Sales Share by Country (2021-2032) Figure 47. Europe Herpes Treatment Revenue Share by Type (2021-2032) Figure 48. Europe Herpes Treatment Sales Share by Type (2021-2032) Figure 49. Europe Herpes Treatment Revenue Share by Application (2021-2032) Figure 50. Europe Herpes Treatment Sales Share by Application (2021-2032) Figure 51. Europe Herpes Treatment Revenue Share by Country (2021-2032) Figure 52. Europe Herpes Treatment Sales Share by Country (2021-2032) Figure 53. China Herpes Treatment Revenue Share by Type (2021-2032) Figure 54. China Herpes Treatment Sales Share by Type (2021-2032) Figure 55. China Herpes Treatment Revenue Share by Application (2021-2032) Figure 56. China Herpes Treatment Sales Share by Application (2021-2032) Figure 57. Asia Herpes Treatment Revenue Share by Type (2021-2032) Figure 58. Asia Herpes Treatment Sales Share by Type (2021-2032) Figure 59. Asia Herpes Treatment Revenue Share by Application (2021-2032) Figure 60. Asia Herpes Treatment Sales Share by Application (2021-2032) Figure 61. Asia Herpes Treatment Revenue Share by Country (2021-2032) Figure 62. Asia Herpes Treatment Sales Share by Country (2021-2032) Figure 63. SAMEA Herpes Treatment Revenue Share by Type (2021-2032) Figure 64. SAMEA Herpes Treatment Sales Share by Type (2021-2032) Figure 65. SAMEA Herpes Treatment Revenue Share by Application (2021-2032) Figure 66. SAMEA Herpes Treatment Sales Share by Application (2021-2032) Figure 67. SAMEA Herpes Treatment Revenue Share by Country (2021-2032) Figure 68. SAMEA Herpes Treatment Sales Share by Country (2021-2032) Figure 69. Herpes Treatment Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Herpes Treatment Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Famciclovir
  • Valacyclovir
  • Acyclovir
Applications
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • Drug Stores
Companies covered
  • Abbott
  • Teva Pharmaceutical Industries
  • Novartis
  • Merck
  • Mylan
  • GlaxoSmithKline
  • Vical
  • Gilead

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Herpes Treatment Market by Type
  3. 1.2.1 Global Herpes Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Famciclovir
  5. 1.2.3 Valacyclovir
  6. 1.2.4 Acyclovir
  7. 1.3 Herpes Treatment Market by Application
  8. 1.3.1 Global Herpes Treatment Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Retail Pharmacies
  10. 1.3.3 Hospital Pharmacies
  11. 1.3.4 Online Pharmacies
  12. 1.3.5 Drug Stores
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Herpes Treatment Market Dynamics
  1. 2.1 Herpes Treatment Industry Trends
  2. 2.2 Herpes Treatment Industry Drivers
  3. 2.3 Herpes Treatment Industry Opportunities and Challenges
  4. 2.4 Herpes Treatment Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Herpes Treatment Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Herpes Treatment Revenue by Region
  3. 3.2.1 Global Herpes Treatment Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Herpes Treatment Revenue by Region (2021-2026)
  5. 3.2.3 Global Herpes Treatment Revenue by Region (2027-2032)
  6. 3.2.4 Global Herpes Treatment Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Herpes Treatment Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Herpes Treatment Sales by Region
  9. 3.4.1 Global Herpes Treatment Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Herpes Treatment Sales by Region (2021-2026)
  11. 3.4.3 Global Herpes Treatment Sales by Region (2027-2032)
  12. 3.4.4 Global Herpes Treatment Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Herpes Treatment Revenue by Manufacturers
  2. 4.1.1 Global Herpes Treatment Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Herpes Treatment Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Herpes Treatment Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Herpes Treatment Sales by Manufacturers
  6. 4.2.1 Global Herpes Treatment Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Herpes Treatment Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Herpes Treatment Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Herpes Treatment Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Herpes Treatment Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Herpes Treatment Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Herpes Treatment Manufacturers, Product Type & Application
  13. 4.7 Global Herpes Treatment Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Herpes Treatment Market CR5 and HHI
  16. 4.8.2 2025 Herpes Treatment Tier 1, Tier 2, and Tier 3
5 Herpes Treatment Market by Type
  1. 5.1 Global Herpes Treatment Revenue by Type
  2. 5.1.1 Global Herpes Treatment Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Herpes Treatment Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Herpes Treatment Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Herpes Treatment Sales by Type
  6. 5.2.1 Global Herpes Treatment Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Herpes Treatment Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Herpes Treatment Sales Market Share by Type (2021-2032)
  9. 5.3 Global Herpes Treatment Price by Type
6 Herpes Treatment Market by Application
  1. 6.1 Global Herpes Treatment Revenue by Application
  2. 6.1.1 Global Herpes Treatment Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Herpes Treatment Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Herpes Treatment Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Herpes Treatment Sales by Application
  6. 6.2.1 Global Herpes Treatment Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Herpes Treatment Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Herpes Treatment Sales Market Share by Application (2021-2032)
  9. 6.3 Global Herpes Treatment Price by Application
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Herpes Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Herpes Treatment Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Teva Pharmaceutical Industries
  8. 7.2.1 Teva Pharmaceutical Industries Company Information
  9. 7.2.2 Teva Pharmaceutical Industries Business Overview
  10. 7.2.3 Teva Pharmaceutical Industries Herpes Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Teva Pharmaceutical Industries Herpes Treatment Product Portfolio
  12. 7.2.5 Teva Pharmaceutical Industries Recent Developments
  13. 7.3 Novartis
  14. 7.3.1 Novartis Company Information
  15. 7.3.2 Novartis Business Overview
  16. 7.3.3 Novartis Herpes Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Novartis Herpes Treatment Product Portfolio
  18. 7.3.5 Novartis Recent Developments
  19. 7.4 Merck
  20. 7.4.1 Merck Company Information
  21. 7.4.2 Merck Business Overview
  22. 7.4.3 Merck Herpes Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Merck Herpes Treatment Product Portfolio
  24. 7.4.5 Merck Recent Developments
  25. 7.5 Mylan
  26. 7.5.1 Mylan Company Information
  27. 7.5.2 Mylan Business Overview
  28. 7.5.3 Mylan Herpes Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Mylan Herpes Treatment Product Portfolio
  30. 7.5.5 Mylan Recent Developments
  31. 7.6 GlaxoSmithKline
  32. 7.6.1 GlaxoSmithKline Company Information
  33. 7.6.2 GlaxoSmithKline Business Overview
  34. 7.6.3 GlaxoSmithKline Herpes Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 GlaxoSmithKline Herpes Treatment Product Portfolio
  36. 7.6.5 GlaxoSmithKline Recent Developments
  37. 7.7 Vical
  38. 7.7.1 Vical Company Information
  39. 7.7.2 Vical Business Overview
  40. 7.7.3 Vical Herpes Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Vical Herpes Treatment Product Portfolio
  42. 7.7.5 Vical Recent Developments
  43. 7.8 Gilead
  44. 7.8.1 Gilead Company Information
  45. 7.8.2 Gilead Business Overview
  46. 7.8.3 Gilead Herpes Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Gilead Herpes Treatment Product Portfolio
  48. 7.8.5 Gilead Recent Developments
8 North America
  1. 8.1 North America Herpes Treatment Market Size by Type
  2. 8.1.1 North America Herpes Treatment Revenue by Type (2021-2032)
  3. 8.1.2 North America Herpes Treatment Sales by Type (2021-2032)
  4. 8.1.3 North America Herpes Treatment Price by Type (2021-2032)
  5. 8.2 North America Herpes Treatment Market Size by Application
  6. 8.2.1 North America Herpes Treatment Revenue by Application (2021-2032)
  7. 8.2.2 North America Herpes Treatment Sales by Application (2021-2032)
  8. 8.2.3 North America Herpes Treatment Price by Application (2021-2032)
  9. 8.3 North America Herpes Treatment Market Size by Country
  10. 8.3.1 North America Herpes Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Herpes Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Herpes Treatment Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Herpes Treatment Market Size by Type
  2. 9.1.1 Europe Herpes Treatment Revenue by Type (2021-2032)
  3. 9.1.2 Europe Herpes Treatment Sales by Type (2021-2032)
  4. 9.1.3 Europe Herpes Treatment Price by Type (2021-2032)
  5. 9.2 Europe Herpes Treatment Market Size by Application
  6. 9.2.1 Europe Herpes Treatment Revenue by Application (2021-2032)
  7. 9.2.2 Europe Herpes Treatment Sales by Application (2021-2032)
  8. 9.2.3 Europe Herpes Treatment Price by Application (2021-2032)
  9. 9.3 Europe Herpes Treatment Market Size by Country
  10. 9.3.1 Europe Herpes Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Herpes Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Herpes Treatment Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Herpes Treatment Market Size by Type
  2. 10.1.1 China Herpes Treatment Revenue by Type (2021-2032)
  3. 10.1.2 China Herpes Treatment Sales by Type (2021-2032)
  4. 10.1.3 China Herpes Treatment Price by Type (2021-2032)
  5. 10.2 China Herpes Treatment Market Size by Application
  6. 10.2.1 China Herpes Treatment Revenue by Application (2021-2032)
  7. 10.2.2 China Herpes Treatment Sales by Application (2021-2032)
  8. 10.2.3 China Herpes Treatment Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Herpes Treatment Market Size by Type
  2. 11.1.1 Asia Herpes Treatment Revenue by Type (2021-2032)
  3. 11.1.2 Asia Herpes Treatment Sales by Type (2021-2032)
  4. 11.1.3 Asia Herpes Treatment Price by Type (2021-2032)
  5. 11.2 Asia Herpes Treatment Market Size by Application
  6. 11.2.1 Asia Herpes Treatment Revenue by Application (2021-2032)
  7. 11.2.2 Asia Herpes Treatment Sales by Application (2021-2032)
  8. 11.2.3 Asia Herpes Treatment Price by Application (2021-2032)
  9. 11.3 Asia Herpes Treatment Market Size by Country
  10. 11.3.1 Asia Herpes Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Herpes Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Herpes Treatment Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Herpes Treatment Market Size by Type
  2. 12.1.1 SAMEA Herpes Treatment Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Herpes Treatment Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Herpes Treatment Price by Type (2021-2032)
  5. 12.2 SAMEA Herpes Treatment Market Size by Application
  6. 12.2.1 SAMEA Herpes Treatment Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Herpes Treatment Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Herpes Treatment Price by Application (2021-2032)
  9. 12.3 SAMEA Herpes Treatment Market Size by Country
  10. 12.3.1 SAMEA Herpes Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Herpes Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Herpes Treatment Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Herpes Treatment Value Chain Analysis
  2. 13.1.1 Herpes Treatment Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Herpes Treatment Production Mode & Process
  6. 13.2 Herpes Treatment Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Herpes Treatment Distributors
  9. 13.2.3 Herpes Treatment Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst